Cytek Biosciences (CTKB) Net Cash Flow (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Net Cash Flow came in at -$25.8 million in Q1 2026, down 1064.74% YoY from $2.7 million in Q1 2025, and down 572.94% on a QoQ basis from -$3.8 million in Q4 2025.
Cytek Biosciences (CTKB) Net Cash Flow (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Net Cash Flow data on file, last reported at -$25.8 million in Q1 2026.
- Quarterly Net Cash Flow fell 1064.74% year-over-year to -$25.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.6 million (up 58.1% YoY) and the FY2025 annual result came in at -$8.0 million, up 89.1% from the prior year.
- Net Cash Flow eased to -$25.8 million in Q1 2026, from -$3.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $30.6 million in Q3 2023 to a low of -$166.0 million in Q1 2023.
- A 5-year average of -$17.7 million and a median of -$3.8 million in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow plunged 8656.12% — and 2024, when it jumped 4076.28%.
- Tracing CTKB's Net Cash Flow over 5 years: stood at -$41.0 million in 2022, then jumped by 111.76% to $4.8 million in 2023, then tumbled by 1449.0% to -$65.1 million in 2024, then jumped by 94.1% to -$3.8 million in 2025, then sank by 572.94% to -$25.8 million in 2026.
- The last three Net Cash Flow figures came in at -$25.8 million (Q1 2026), -$3.8 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | 7.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.58 Mn |
| Jun 30, 2026 | 7.58 Mn |
| Mar 31, 2026 | -25.83 Mn |
| Mar 31, 2026 | -25.83 Mn |
| Dec 31, 2025 | -3.84 Mn |
| Dec 31, 2025 | -3.84 Mn |
| Sep 30, 2025 | 16.96 Mn |
| Sep 30, 2025 | 16.96 Mn |
| Jun 30, 2025 | -18.91 Mn |
| Jun 30, 2025 | -18.91 Mn |
| Mar 31, 2025 | -2.22 Mn |
| Mar 31, 2025 | -2.22 Mn |
| Dec 31, 2024 | -65.08 Mn |
| Dec 31, 2024 | -65.08 Mn |
| Sep 30, 2024 | -14.67 Mn |
| Sep 30, 2024 | -14.67 Mn |
| Jun 30, 2024 | 6.52 Mn |
| Jun 30, 2024 | 6.52 Mn |
| Mar 31, 2024 | -184,000.00 |
| Mar 31, 2024 | -184,000.00 |